Expanding roles of ABCG1 and sterol transport

Current Opinion in Lipidology

Volumn 24, Issue 2, 2013, Pages 138-146

  Tarling, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

intracellular; sterol; transporter

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ACETYL COENZYME A; BILE SALT; CHOLESTEROL; CHYLOMICRON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; OXYSTEROL; PHOSPHOLIPID; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; SUCROSE; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID SEQUENCE; BIOTINYLATION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CENTRIFUGATION; CONTROLLED STUDY; DNA HAIRPIN; GALLSTONE; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOFLUORESCENCE; INSULIN RESPONSE; KNOCKOUT MOUSE; LEUKOCYTOSIS; LYMPHOCYTE; MAMMAL CELL; NONHUMAN; OXIDATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STEM CELL; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHOLESTEROL; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MACROPHAGES; MICE; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

MUS;

EID: 84875229718     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32835da122     Document Type: Review

References (90)

1. Higgins CF. ABC transporters: from microorganisms to man. Ann Rev Cell Biol 1992; 8: 67-113.
2. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001; 42: 1007-1017.
3. Graf GA, Li WP, Gerard RD, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002; 110: 659-669.
4. Mulugeta S, Gray JM, Notarfrancesco KL, et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002; 277: 22147-22155.
5. Neufeld EB, Remaley AT, Demosky SJ, et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001; 276: 27584-27590.
6. Tarling EJ, Edwards PA. ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter. Proc Natl Acad Sci USA 2011; 108: 19719-19724. ABCG1 is an intracellular transporter and is undetectable at the cell surface. First demonstration that the transmembrane domains of ABCG1 are sufficient for localization and function.
7. Tarr PT, Edwards PA. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J Lipid Res 2008; 49: 169-182.
8. Martin LJ, Lau E, Singh H, et al. ABCC6 localizes to the mitochondriaassociated membrane/novelty and significance. Circ Res 2012; 111: 516-520.
9. Vedhachalam C, Duong PT, Nickel P, et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-1 and formation of high density lipoprotein particles. J Biol Chem 2007; 282: 25123-25130.
10. Tarling EJ, Bojanic DD, Tangirala RK, et al. Impaired development of atherosclerosis in Abcg1-/-Apoe-/-mice: identification of specific oxysterols that both accumulate in Abcg1-/-Apoe-/-tissues and induce apoptosis. Arterioscler Thromb Vasc Biol 2010; 30: 1174-1180.
11. Terasaka N, Wang N, Yvan-Charvet L, Tall AR. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 2007; 104: 15093-15098.
12. Vaughan AM, Oram JF. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem 2005; 280: 30150-30157.
13. Wang N, Lan D, Chen W, et al. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J 2004; 22: 1073-1082.
14. Wang J, Sun F, Zhang DW, et al. Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution. J Biol Chem 2006; 281: 27894-27904.
15. Wang J, Zhang D, Lei Y, et al. Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8. Biochemistry 2008; 47: 5194-5204.
16. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347-351.
17. Lawn RM, Wade DP, Garvin MR, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104: R25-R31.
18. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adajacent ABC transporters. Science 2000; 290: 1771-1775.
19. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-1 in Tangier disease. J Clin Invest 1995; 96: 78-87.
20. Herbert PN, Forte T, Heinen RJ, Fredrickson DS. Tangier disease: one explanation of lipid storage. N Engl J Med 1978; 299: 519-521.
21. Olson RE. Discovery of the lipoproteins, their role in fat transport and their significance as risk factors. J Nutr 1998; 128: 439S-443S.
22. Hoofnagle AN, Heinecke JW. Lipoproteomics: using mass spectrometrybased proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res 2009; 50: 1967-1975.
23. Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 2009; 50 (Suppl): S15-S27.
24. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-430.
25. Goldstein JL, Brown MS, Anderson RGW, et al. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Ann Rev Cell Biol 1985; 1: 1-39.
26. Hoekstra M, Van Berkel TJC, Van Eck M. Scavanger receptor B1: a multipurpose player in choletserol and steroid metabolism. World J Gastroenterol 2010; 16: 5916-5924.
27. Stephen SL, Freestone K, Dunn S, et al. Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens 2010 [Epub ahead of print]. doi: 10.4061/2010/646929
28. Tarling EJ, Edwards PA. Dancing with the sterols: critical roles for ABCG1, ABCA1, miRNAs, and nuclear and cell surface receptors in controlling cellular sterol homeostasis. Biochim Biophys Acta 2012; 1821: 386-395.
29. McNamara DJ, Ahrens EH, Samuel P, Crouse JR. Measurement of daily cholesterol synthesis rates in man by assay of the fractional conversion of mevalonic acid to cholesterol. Proc Natl Acad Sci 1977; 74: 3043-3046.
30. Morello F, Saglio E, Noghero A, et al. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 2009; 207: 38-44.
31. Jusakul A, Loilome W, Namwat N, et al. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Mutation Res 2012; 731: 48-57.
32. Biasi F, Chiarpotto E, Sottero B, et al. Evidence of cell damage induced by major components of a diet-compatible mixture of oxysterols in human colon cancer CaCo-2 cell line. Biochimie 2012 [Epub ahead of print]. doi: 10.1016/j.biochi.2012.10.011
33. Spencer TA. The squalene dioxide pathway of steroid biosynthesis. Accounts Chem Res 1994; 27: 83-90.
34. Luoma PV. Cytochrome P450: physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Ann Med 2007; 39: 359-370.
35. Bjorkhem I. Five decades with oxysterols. Biochimie 2012.
36. Brown AJ, Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Molec Aspects Med 2009; 30: 111-122.
37. Adams CM, Reitz J, De Brabander JK, et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem 2004; 279: 52772-52780.
38. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metabolism 2008; 8: 512-521.
39. Radhakrishnan A, Ikeda Y, Kwon HJ, et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci 2007; 104: 6511-6518.
40. Janowski BA, Grogan MJ, Jones SA, et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci 1999; 96: 266-271.
41. Bjorkhem I. Are side-chain oxidized oxysterols regulators also in vivo? J Lipid Res 2009; 50: S213-S218.
42. Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 1513-1518.
43. Torocsik D, Szanto A, Nagy L. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Molec Aspects Med 2009; 30: 134-152.
44. Spann NJ, Garmire LX, McDonald JG, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012; 151: 138-152. Identification of an intermediate of the cholesterol biosynthetic pathway as a LXR agonist.
45. Kennedy MA, Venkateswaran A, Tarr PT, et al. Characterization of the human ABCG1 gene. Liver X receptor activates an internal promoter that producecs a novel transcript encoding an alternative form of the protein. J Biol Chem 2001; 276: 39438-39447.
46. Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005; 1: 121-131.
47. Sabol SL, Brewer HB Jr, Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 2005; 46: 2151-2167.
48. Tarr PT, Tarling EJ, Bojanic DD, et al. Emerging new paradigms for ABCG transporters. Biochim Biophys Acta 2009; 1791: 584-593.
49. Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC transporter. Nature 2006; 443: 180-185.
50. Higgins CF, Linton KJ. The ATP switch model for ABC transporters. Nat Struct Mol Biol 2004; 11: 918-926.
51. Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on new recent research. Cell Mol Life Sci 2004; 61: 682-699.
52. Graf GA, Yu L, Li WP, et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 2003; 278: 48275-48282.
53. Kobayashi A, Takanezawa Y, Hirata T, et al. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res 2006; 47: 1791-1802.
54. Mo W, Zhang JT. Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease. Expert Opin Drug Metab Toxicol 2009; 5: 1049-1063.
55. Burgess B, Naus K, Chan J, et al. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 1731-1737.
56. Christiansen-Weber TA, Voland JR, Wu Y, et al. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol 2000; 157: 1017-1029.
57. Fredrickson DS. The inheritance of high density lipoprotein deficiency (Tangier disease). J Clin Investig 1964; 43: 228-236.
58. Bates SR, et al. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L980-L989.
59. Out R, Hoekstra M, Habets K, et al. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 2008; 28: 258-264.
60. Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007; 117: 3900-3908.
61. Baldan A, Tarr PT, Vales CS, et al. Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis. J Biol Chem 2006; 281: 29401-29410.
62. Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-B1, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007; 117: 2216-2224.
63. Baldan A, Pei L, Lee R, et al. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/-and ApoE-/-mice transplanted with Abcg1-/-bone marrow. Arterioscler Thromb Vasc Biol 2006; 26: 2301-2307.
64. Out R, Hoekstra M, Hildebrand RB, et al. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 2295-2300.
65. Ranalletta M, Wang N, Han S, et al. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/-bone marrow. Arterioscler Thromb Vasc Biol 2006; 26: 2308-2315.
66. Curtiss LK. Is Two out of Three Enough for ABCG1? Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26: 2175-2177.
67. Lammers B, Out R, Hildebrand RB, et al. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development. Atherosclerosis 2009; 205: 420-426.
68. Meurs I, Lammers B, Zhao Y, et al. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Atherosclerosis 2012; 221: 41-47. The stage of atherosclerotic disease impacts the effect loss of ABCG1 has on the developemtn of atherosclerosis. After 10 weeks of Western diet feeding, Abcg1-/-Ldlr-/-mice had 1.5-fold more atherosclerotic lesions than Ldlr-/-control mice, however after 12 weeks on the Western diet Abcg1-/-Ldlr-/-mice had 1.7-fold less lesions.
69. Gelissen IC, Harris M, Rye KA, et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I. Arterioscler Thromb Vasc Biol 2006; 26: 534-540.
70. Nakamura K, Kennedy MA, Baldan A, et al. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem 2004; 279: 45980-45989.
71. Sankaranarayanan S, Oram JF, Asztalos BF, et al. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J Lipid Res 2009; 50: 275-284.
72. Wang N, Lan D, Chen W, et al. ATP-binding cassette transportersG1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004; 101: 9774-9779.
73. Wang N, Ranalletta M, Matsuura F, et al. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 2006; 26: 1310-1316.
74. Xie Q, Engel T, Schnoor M, et al. Cell surface localization of ABCG1 does not require LXR activation. Arterioscler Thromb Vasc Biol 2006; 26: e143-e144.
75. Sturek JM, Castle JD, Trace AP, et al. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J Clin Invest 2010; 120: 2575-2589.
76. Gao X, Gu H, Li G, et al. Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux. Biochimica Biophysica Acta 2012; 1821: 552-559.
77. Engel T, Kannenberg F, Fobker M, et al. Expression of ATP binding cassettetransporter ABCG1 prevents cell death by transporting cytotoxic 7[beta]-hydroxycholesterol. FEBS Lett 2007; 581: 1673-1680.
78. Bensinger SJ, Bradley MN, Joseph SB, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008; 134: 97-111.
79. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J Immunol 2010; 184: 173-183.
80. Westerterp M, Gourion-Arsiquaud S, Murphy AJ, et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell stem cell 2012; 11: 195-206.
81. Yvan-Charvet L, Pagler TA, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010; 328: 1689-1693.
82. Langhi C, Cariou B. Cholesterol metabolism and beta-cell function. Med Sci (Paris) 2010; 26: 385-390.
83. Schou J, Tybjorg-Hansen A, Muller HJ, et al. ABC transporter genes and risk of type 2 diabetes: a study of 40, 000 individuals from the general population. Diabetes Care 2012; 35: 2600-2606.
84. Bojanic DD, Tarr PT, Gale GD, et al. Differential expression and function of ABCG1 and ABCG4 during development and ageing. J Lipid Res 2009; 51: 169-181.
85. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998; 1408: 79-89.
86. Veldhuizen R, Nag K, Orgeig S, Possmayer F. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998; 1408: 90-108.
87. Chander A, Fisher AB. Regulation of lung surfactant secretion. Am J Physiol Lung Cell Mol Physiol 1990; 258: L241-L253.
88. Fitzgerald ML, Xavier R, Hayley KJ, et al. ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 2007; 48: 621-632.
89. Thomassen MJ, Barna BP, Malur AG, et al. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res 2007; 48: 2762-2768.
90. Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol 2010; 135: 223-235.